Xiao‐Ben Pan

1.6k total citations
41 papers, 1.2k citations indexed

About

Xiao‐Ben Pan is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Xiao‐Ben Pan has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 23 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in Xiao‐Ben Pan's work include Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (9 papers). Xiao‐Ben Pan is often cited by papers focused on Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (9 papers). Xiao‐Ben Pan collaborates with scholars based in China, United States and Norway. Xiao‐Ben Pan's co-authors include Ju‐Tao Guo, Timothy M. Block, Jinhong Chang, Dong Jiang, Jessica M. Weidner, Haitao Guo, Lai Wei, Chunxiao Xu, Xianchao Zhang and Min Qing and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Xiao‐Ben Pan

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao‐Ben Pan China 15 472 399 365 294 282 41 1.2k
Yongfen Xu China 18 411 0.9× 310 0.8× 267 0.7× 320 1.1× 263 0.9× 29 1.0k
Arash Memarnejadian Iran 20 305 0.6× 376 0.9× 247 0.7× 327 1.1× 148 0.5× 73 1.1k
Roberta A. Diotti Italy 19 438 0.9× 198 0.5× 323 0.9× 271 0.9× 228 0.8× 37 1.1k
Scott Preiss Australia 14 365 0.8× 352 0.9× 220 0.6× 337 1.1× 109 0.4× 22 1.0k
Fereidoun Mahboudi Iran 20 415 0.9× 282 0.7× 109 0.3× 370 1.3× 159 0.6× 77 1.1k
Yongshui Fu China 23 837 1.8× 331 0.8× 240 0.7× 334 1.1× 784 2.8× 120 1.8k
MP Busch United States 20 522 1.1× 292 0.7× 403 1.1× 211 0.7× 295 1.0× 42 1.4k
Chengyao Li China 24 846 1.8× 218 0.5× 334 0.9× 344 1.2× 704 2.5× 124 1.8k
Zohreh Sharifi Iran 15 410 0.9× 144 0.4× 132 0.4× 159 0.5× 218 0.8× 130 844
Andrew M. Lee United States 17 289 0.6× 711 1.8× 454 1.2× 310 1.1× 79 0.3× 22 1.4k

Countries citing papers authored by Xiao‐Ben Pan

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Ben Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Ben Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Ben Pan more than expected).

Fields of papers citing papers by Xiao‐Ben Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Ben Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Ben Pan. The network helps show where Xiao‐Ben Pan may publish in the future.

Co-authorship network of co-authors of Xiao‐Ben Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Ben Pan. A scholar is included among the top collaborators of Xiao‐Ben Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Ben Pan. Xiao‐Ben Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Weinan, et al.. (2024). Repurposing of a library for high-content screening of inhibitors against Echinococcus granulosus. Parasites & Vectors. 17(1). 373–373.
2.
Zhang, Huiqing, Shiyi Liu, Liping Chen, et al.. (2023). Alleviated symptoms of SARS‐CoV‐2 Omicron variant infection in chronic hepatitis B patients with immune control. Journal of Medical Virology. 95(10). e29173–e29173.
3.
Liu, Jing, Haifeng Lv, Jie Wang, et al.. (2022). Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease. Annals of Hepatology. 28(2). 100892–100892. 14 indexed citations
4.
Lu, Yuqing, Jing Wu, Hui Ma, et al.. (2021). Interferon Gamma-Inducible Protein 16 of Peripheral Blood Mononuclear Cells May Sense Hepatitis B Virus Infection and Regulate the Antiviral Immunity. Frontiers in Cellular and Infection Microbiology. 11. 790036–790036. 5 indexed citations
5.
Zhang, Yuting, et al.. (2021). Successful treatment of infantile hepatitis B with lamivudine: A case report. World Journal of Clinical Cases. 9(14). 3442–3448.
6.
Wu, Jing, Yanxiu Ma, Yanhua Kang, et al.. (2020). DDX5-targeting fully human monoclonal autoantibody inhibits proliferation and promotes differentiation of acute promyelocytic leukemia cells by increasing ROS production. Cell Death and Disease. 11(7). 552–552. 12 indexed citations
7.
Pan, Xiao‐Ben. (2020). Application of personal-oriented digital technology in preventing transmission of COVID-19, China. Irish Journal of Medical Science (1971 -). 189(4). 1145–1146. 62 indexed citations
8.
Zhao, Xingliang, et al.. (2015). Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold. Scientific Reports. 5(1). 17640–17640. 31 indexed citations
9.
Pan, Xiao‐Ben, et al.. (2013). BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells. Antiviral Research. 98(1). 54–60. 34 indexed citations
10.
Ma, Hui, Xingliang Zhao, Xueyan Wang, et al.. (2013). 2’,3’-Cyclic Nucleotide 3’-Phosphodiesterases Inhibit Hepatitis B Virus Replication. PLoS ONE. 8(11). e80769–e80769. 7 indexed citations
11.
Liu, Ruyu, Huiying Rao, Jianghua Wang, et al.. (2013). Determination of the Human Antibody Response to the Neutralization Epitopes Encompassing Amino Acids 313–327 and 432–443 of Hepatitis C Virus E1E2 Glycoproteins. PLoS ONE. 8(6). e66872–e66872. 6 indexed citations
12.
Pan, Xiao‐Ben, et al.. (2012). BST2/Tetherin Inhibits Dengue Virus Release from Human Hepatoma Cells. PLoS ONE. 7(12). e51033–e51033. 40 indexed citations
13.
Pan, Xiao‐Ben, Hui Ma, Jin Qian, & Lai Wei. (2011). Characterization of microRNA expression profiles associated with hepatitis B virus replication and clearance in vivo and in vitro. Journal of Gastroenterology and Hepatology. 27(4). 805–812. 21 indexed citations
14.
Pan, Xiao‐Ben, et al.. (2010). Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production. Antiviral Research. 89(1). 109–114. 12 indexed citations
15.
Pan, Xiao‐Ben, et al.. (2010). Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein. Virus Research. 150(1-2). 129–134. 6 indexed citations
16.
Jiang, Dong, Jessica M. Weidner, Min Qing, et al.. (2010). Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections. Journal of Virology. 84(16). 8332–8341. 280 indexed citations
17.
Pan, Xiao‐Ben, et al.. (2007). Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns. Archives of Virology. 152(6). 1159–1173. 8 indexed citations
18.
Pan, Xiao‐Ben, et al.. (2007). Cellular chromosome DNA interferes with fluorescence quantitative real‐time PCR detection of HBV DNA in culture medium. Journal of Medical Virology. 80(1). 47–52. 5 indexed citations
19.
Pan, Xiao‐Ben, et al.. (2006). Hematopoietic Stem Cell Mobilization After Rat Partial Orthotopic Liver Transplantation. Transplantation Proceedings. 38(5). 1603–1609. 6 indexed citations
20.
Liu, Feng, Xiao‐Ben Pan, Guodong Chen, et al.. (2006). Hematopoietic stem cells mobilized by granulocyte colony-stimulating factor partly contribute to liver graft regeneration after partial orthotopic liver transplantation. Liver Transplantation. 12(7). 1129–1137. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongfen Xu Breakdown of academic impact, for papers by Arash Memarnejadian Breakdown of academic impact, for papers by Roberta A. Diotti Breakdown of academic impact, for papers by Scott Preiss Breakdown of academic impact, for papers by Fereidoun Mahboudi Breakdown of academic impact, for papers by Yongshui Fu Breakdown of academic impact, for papers by MP Busch Breakdown of academic impact, for papers by Chengyao Li Breakdown of academic impact, for papers by Zohreh Sharifi Breakdown of academic impact, for papers by Andrew M. Lee
Rankless by CCL
2026